World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
34586
World Ranking
13488
National Ranking
1256

Attila T. Lorincz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Attila T. Lorincz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 248 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Attila T. Lorincz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Attila T. Lorincz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Attila T. Lorincz is affiliated with Queen Mary University of London in the United Kingdom. Their research primarily focuses on the study of cervical cancer and human papillomavirus (HPV), exploring epigenetics and DNA methylation in relation to cancer biology and molecular diagnostics.

The scientist has contributed to multiple research articles published in notable venues including the International Journal of Cancer, PLoS ONE, and Cancer Medicine. Recent publications encompass the following:

  • Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide study (2021, International Journal of Cancer)
  • Effective methylation triage of HPV positive women with abnormal cytology in a middle-income country (2020, International Journal of Cancer)
  • DNA methylation testing with S5 for triage of high-risk HPV positive women (2022, International Journal of Cancer)
  • Performance of an affordable urine self-sampling method for human papillomavirus detection in Mexican women (2021, PLoS ONE)
  • Consistency of the S5 DNA methylation classifier in formalin-fixed biopsies versus corresponding exfoliated cells for the detection of pre-cancerous cervical lesions (2021, Cancer Medicine)

Coauthorship patterns indicate collaborations with researchers such as Jack Cuzick, Belinda Nedjai, László Friedrich, Adrienn Tóth, and Cosette M. Wheeler. These coauthors have worked alongside Lorincz on multiple occasions, reflecting ongoing research partnerships.

The main fields of study in which Attila T. Lorincz is active include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine
  • Agricultural and Biological Sciences

Within these disciplines, subfields of emphasis include:

  • Molecular Biology
  • Epidemiology
  • Animal Science and Zoology
  • Biotechnology
  • Cancer Research

The key research topics covered by Lorincz's work span:

  • Cervical Cancer and HPV Research
  • Meat and Animal Product Quality
  • Epigenetics and DNA Methylation
  • Microbial Inactivation Methods
  • Cancer-related molecular mechanisms research
  • Hepatitis B Virus Studies
  • Molecular Biology Techniques and Applications

Publications by Attila T. Lorincz are frequently found in the following journals:

  • International Journal of Cancer
  • Applied Sciences
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Review on Agriculture and Rural Development
  • PLoS ONE

Best Publications

  • The causal relation between human papillomavirus and cervical cancer

    F X Bosch;A Lorincz;N Muñoz;C J L M Meijer

  • The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice

    Michelle J. Khan;Philip E. Castle;Attila T. Lorincz;Sholom Wacholder

  • Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types.

    A T Lorincz;R Reid;A B Jenson;M D Greenberg

  • Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm.

    A P Cullen;R Reid;M Campion;A T Lörincz

  • HPV DNA testing in cervical cancer screening. Results from women in a high-risk province of Costa Rica.

    Mark Schiffman;Rolando Herrero;Allan Hildesheim;Mark E. Sherman

  • HPV DNA Testing of Self‐Collected Vaginal Samples Compared With Cytologic Screening To Detect Cervical Cancer

    Thomas C. Wright;Lynette Denny;Louise Kuhn;Amy Pollack

  • The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in colombia and spain

    N. Munoz;F. X. Bosch;S. de Sanjose;L. Tafur

  • Comprehensive control of human papillomavirus infections and related diseases.

    F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki

  • Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage

    Theodore D. Kessis;Robert J. Slebos;William G. Nelson;Michael B. Kastan

  • Baseline Cytology, Human Papillomavirus Testing, and Risk for Cervical Neoplasia: A 10-Year Cohort Analysis

    Mark E. Sherman;Attila T. Lorincz;David R. Scott;Sholom Wacholder

  • A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China

    You-lin Qiao;John W. Sellors;John W. Sellors;Paul S. Eder;Yan-ping Bao

  • Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.

    J.Thomas Cox;Attila T. Lorincz;Mark H. Schiffman;Mark E. Sherman

  • Protein kinase activity associated with the product of the yeast cell division cycle gene CDC28.

    Steven I. Reed;Jeffrey A. Hadwiger;Attila T. Lorincz

  • Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia.

    J. Belinson;Y.L. Qiao;R. Pretorius;W.H. Zhang

  • Primary structure homology between the product of yeast cell division control gene CDC28 and vertebrate oncogenes

    Attila T. Lörincz;Steven I. Reed

  • Oncogenic Association of Specific Human Papillomavirus Types With Cervical Neoplasia

    A. T. Lorincz;G. F. Temple;R. J. Kurman;A. B. Jenson

  • Viral load of human papillomavirus and risk of CIN3 or cervical cancer.

    Attila T Lorincz;Philip E Castle;Mark E Sherman;David R Scott

  • Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada

    John W. Sellors;James B. Mahony;Janusz Kaczorowski;Alice Lytwyn

  • HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica

    A Hildesheim;R Herrero;P E Castle;S Wacholder

  • HPV testing in primary screening of older women.

    J Cuzick;E Beverley;L Ho;G Terry

Frequent Co-Authors

Mark Schiffman
Mark Schiffman National Institutes of Health
Mark E. Sherman
Mark E. Sherman Mayo Clinic
Jack Cuzick
Jack Cuzick Queen Mary University of London
Allan Hildesheim
Allan Hildesheim National Institutes of Health
Sholom Wacholder
Sholom Wacholder National Institutes of Health
Robert D. Burk
Robert D. Burk Albert Einstein College of Medicine
Robert J. Kurman
Robert J. Kurman Johns Hopkins University
Keerti V. Shah
Keerti V. Shah Johns Hopkins University
Rolando Herrero
Rolando Herrero Costa Rican Agency for Biomedical Research, INCIENSA Foundation
Philip E. Castle
Philip E. Castle National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in building a healthcare career beyond a traditional M.D. pathway? There are several flexible and affordable online degrees that can help you enter the field. Many students first look into nursing, where online options are growing. If you’re already an RN, the cheapest rn to bsn programs offer a cost-effective route to advance your degree without putting your career on hold.

Those holding a bachelor’s in another field might consider fast-tracked direct entry msn programs for non-nursing majors online for a streamlined transition into advanced nursing roles. Similarly, aspiring nurses can explore online bsn programs for non nurses—great for those switching careers or seeking flexible learning options.

Don’t overlook healthcare admin and support careers. Medical billing and coding are in high demand, and numerous accredited medical billing and coding schools online with financial aid make entering this field accessible and affordable. Choosing the right online program can open a wide range of rewarding opportunities in the U.S. medical sector.

Best Scientists Citing Attila T. Lorincz

Trending Scientists

Recently Published Articles